Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Chakravarthy

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Methods in Enzymology|July 4, 2016
In Vitro Chromatin Assembly: Strategies and Quality ControlU Muthurajan, F Mattiroli, S Bergeron, et al.
Optics Letters|October 30, 2009
Use of radio-frequency-pulse surface acoustic wave profilometry for passband engineering of acousto-optic tunable filtersH Rashid, D A Smith, Z Bao, et al.
Helicobacter|November 16, 2007
Prevalence of duodenal ulcer-promoting gene (dupA) of Helicobacter pylori in patients with duodenal ulcer in North Indian populationH S Jayasinghe Arachchi, Vijay Kalra, Banwari Lal, et al.
IJID Regions|April 3, 2025
Safety and immunogenicity of Biological E's typhoid conjugate vaccine TYPHIBEV<sup>Ⓡ</sup> concomitantly administered with measles rubella vaccine: a phase IV prospective, multicenter studySubhash Thuluva, Ramesh V Matur, SubbaReddy Gunneri, et al.
Ageing Research Reviews|February 27, 2026
An update on the monogenic causes of Parkinson's disease: Impact on patient stratification and personalised medicineSakeena Asmi, Anand Krishnan, Sneha Mary Alexander, et al.
The Lancet Regional Health. Southeast Asia|March 11, 2026
Immunogenicity and safety of biological E's 14-valent pneumococcal conjugate vaccine (PNEUBEVAX 14®) administered in a 2p + 1 schedule to healthy infants: a multicenter, randomized, active controlled, single-blind, phase III trialSubhash Thuluva, Ramesh V Matur, Subbareddy Gunneri, et al.
Vaccine|April 2, 2025
A double-blind, randomised phase III clinical trial to evaluate safety, immunogenicity, non-inferiority & lot to lot consistency of single component oral cholera vaccine BBV131 (Hillchol®) in comparison to Shanchol™Krishna Mohan Vadrevu, Abhishek Chavan, Amit Chawla, et al.
Vaccines|June 25, 2026
Safety, Immunogenicity of Co-Administered Vaccines, and Lot-to-Lot Consistency of a 14-Valent Pneumococcal Conjugate Vaccine (PNEUBEVAX 14<sup>®</sup>) Administered at 6-10-14 Weeks in Healthy Infants: A Multicenter, Phase IV TrialSubhash Thuluva, Subbareddy Gunneri, Siddalingaiah Ningaiah, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Methods in Enzymology|July 4, 2016
In Vitro Chromatin Assembly: Strategies and Quality ControlU Muthurajan, F Mattiroli, S Bergeron, et al.
Optics Letters|October 30, 2009
Use of radio-frequency-pulse surface acoustic wave profilometry for passband engineering of acousto-optic tunable filtersH Rashid, D A Smith, Z Bao, et al.
Helicobacter|November 16, 2007
Prevalence of duodenal ulcer-promoting gene (dupA) of Helicobacter pylori in patients with duodenal ulcer in North Indian populationH S Jayasinghe Arachchi, Vijay Kalra, Banwari Lal, et al.
IJID Regions|April 3, 2025
Safety and immunogenicity of Biological E's typhoid conjugate vaccine TYPHIBEV<sup>Ⓡ</sup> concomitantly administered with measles rubella vaccine: a phase IV prospective, multicenter studySubhash Thuluva, Ramesh V Matur, SubbaReddy Gunneri, et al.
Ageing Research Reviews|February 27, 2026
An update on the monogenic causes of Parkinson's disease: Impact on patient stratification and personalised medicineSakeena Asmi, Anand Krishnan, Sneha Mary Alexander, et al.
The Lancet Regional Health. Southeast Asia|March 11, 2026
Immunogenicity and safety of biological E's 14-valent pneumococcal conjugate vaccine (PNEUBEVAX 14®) administered in a 2p + 1 schedule to healthy infants: a multicenter, randomized, active controlled, single-blind, phase III trialSubhash Thuluva, Ramesh V Matur, Subbareddy Gunneri, et al.
Vaccine|April 2, 2025
A double-blind, randomised phase III clinical trial to evaluate safety, immunogenicity, non-inferiority & lot to lot consistency of single component oral cholera vaccine BBV131 (Hillchol®) in comparison to Shanchol™Krishna Mohan Vadrevu, Abhishek Chavan, Amit Chawla, et al.
Vaccines|June 25, 2026
Safety, Immunogenicity of Co-Administered Vaccines, and Lot-to-Lot Consistency of a 14-Valent Pneumococcal Conjugate Vaccine (PNEUBEVAX 14<sup>®</sup>) Administered at 6-10-14 Weeks in Healthy Infants: A Multicenter, Phase IV TrialSubhash Thuluva, Subbareddy Gunneri, Siddalingaiah Ningaiah, et al.
Pageof 5